difference between retatrutide and tirzepatide How Is Compared to Tirzepatide? Full Comparison Retatrutide vs Tirzepatide: Key Differences

Standard FDA-approved dosing escalation The FDA-approved tirzepatide dosing schedule, used in the SURMOUNT and SURPASS clinical trials, follows this pattern: Weeks 1 to 4: 2.5 mg once weekly (starting dose) Weeks 5 to 8: 5 mg once weekly Weeks 9 to 12: 7.5 mg once weekly (optional increase) Weeks 13 to 16: 10 mg once weekly (optional increase) Weeks 17 to 20: 12.5 mg once weekly (optional increase) Week 21 and beyond: 15 mg once weekly (maximum dose) Each dose increase happens after a minimum of four weeks at the current dose

En este caso, no te lo inyectes

Obesity during pregnancy is associated with higher rates of gestational diabetes, preeclampsia, cesarean delivery, and neonatal complications

For best results and to minimize any associated side effects, its important that patients adhere to the prescribed dosing schedule and communicate any concerns with a healthcare provider to manage these side effects effectively